Evidence map›Paper›PMID 42758759›Full record

ArticlePLoS genetics2026

Dual contributions of Xrp1 to genome integrity through the DNA damage response and cell competition.

Chaitali Khan, Nasser M Rusan, Nicholas E Baker

Abstract read
In one paragraph

Article in PLoS genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Chaitali KhanDepartment of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America.
Nasser M RusanCell and Developmental Biology Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, United States of America.
Nicholas E BakerDepartment of Genetics, Albert Einstein College of Medicine, Bronx, New York, United States of America.ORCID https://orcid.org/0000-0002-4250-3488

Funding

WORD PROCESSORP30CA013330 · NCI · YESHIVA UNIVERSITY · PI Ulrich Steidl · 1985 to 2026
$111.2M
Regulation of Centrosome Asymmetry in Stem CellsZIAHL006126 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI RUSAN, NASSER · 2011 to 2025
$19.4M
Cell Competition in Development and HomeostasisR01CA284362 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Nicholas E Baker · 2024 to 2026
$2.0M
Advanced Confocal Microscope in a multi-user facilityS10OD023591 · OD · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI BAKER, NICHOLAS E · 2017 to 2017
$590k
Intramural NIH HHS ZIA HL006126NCI NIH HHS P30 CA013330NCI NIH HHS R01 CA284362NIH HHS S10 OD023591
6 · The paper itself

Abstract

Model organisms may help understand how p53 suppresses tumorigenesis in mammals. In Drosophila, the primary transcriptional target of p53 is the gene encoding the bZip AT-hook protein Xrp1, which is another transcription factor. We report that Xrp1 mediates multiple functions of p53 in the DNA damage response (DDR), contributing to p53-dependent gene transcription and DNA damage-induced apoptosis. In addition to this role as a p53 effector, a p53-independent role for Xrp1 in cell competition has been described. Cell competition can remove cells whose genome has been altered by DNA damage and repair. During cell competition, Xrp1 is induced by RpS12, which acts as a sensor of defective ribosome biogenesis. In irradiated discs, p53-independent RpS12-dependent Xrp1 function began as the DDR came to an end, and was even more prominent if p53 function was reduced. Such p53 inhibition resulted in persistence of DNA damage after irradiation, revealed by γH2Av accumulation. Thus, Xrp1 limited the accumulation of abnormal cells resulting from genotoxicity through both the acute, p53-dependent DDR, and also a later mechanism consistent with cell competition removing cells where DNA repair did not restore the normal genome. Both these processes might contribute to the tumor suppressor function of p53 in mammals.

Indexed as

Cell CompetitionDNA-Binding ProteinsDNA DamageDrosophila ProteinsTumor Suppressor Protein p53AnimalsApoptosisDNA RepairDrosophila melanogasterGenomic InstabilityRibosomal ProteinsDNA-Binding ProteinsDrosophila Proteinsp53 protein, DrosophilaRibosomal ProteinsTumor Suppressor Protein p53Xrp1 protein, Drosophila

Identifiers

PMID42758759
PMCPMC13588501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.